Navigation Links
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
Date:11/19/2008

atient safety is our top priority, hence we have acted quickly to implement the recommendations of the DMC. Working with our development partner, Takeda, we will continue to evaluate the therapeutic potential of motesanib in non-squamous NSCLC and metastatic breast cancer, as well as in other solid tumors."

"NSCLC continues to be an area where new and effective therapies are needed. We look forward to the follow up recommendations from the DMC in order to chart the best path forward for the development of this molecule," said Nancy Simonian, M.D., chief medical officer, Millennium: The Takeda Oncology Company.

MONET1 (Motesanib NSCLC Efficacy and Tolerability Study) Trial Design

This Phase 3, multicenter, randomized, placebo-controlled, double-blind trial has enrolled 1,100 of 1,240 planned patients with advanced NSCLC. Patients with either squamous or non-squamous NSCLC were allowed in this study. Squamous NSCLC is a histological subtype of NSCLC and accounts for approximately one-third of the study population. The primary endpoint is overall survival, and secondary endpoints include progression-free survival, objective response rate in patients with measurable disease, duration of response and safety. Patients were randomized 1:1 to receive carboplatin and paclitaxel administered every three weeks with or without 125 mg motesanib taken daily.

About Motesanib

Co-developed by Amgen, Takeda Pharmaceutical Company, and Millennium: The Takeda Oncology Company, motesanib is an investigational, highly selective, oral agent that is being evaluated for its ability to inhibit angiogenesis by targeting vascular endothelial growth factor receptors 1, 2 and 3 (VEGFR1-3). It is also under investigation for its potential direct anti-tumor activity by targeting a family of proteins called tyrosine kinases, including platelet-derived growth factor receptor (PDGFR), and stem cell facto
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
2. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
3. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
4. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
5. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
6. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
7. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
8. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
9. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 Over-the-counter healthcare costs can be ... a new survey of store brand over-the-counter products ... cold to diabetes, can offer significant savings for ... the Private Label Manufacturers Association, assembled a market ... those essential for treatment of pre-diabetes and diabetes. ...
(Date:3/26/2015)... , March 26, 2015 A new ... that comparative effectiveness research (CER) will yield improvements ... yet seeing the impact of CER in the ... annual survey of stakeholders shows that they view ... impact on health care and decision-making in the ...
(Date:3/26/2015)... -- Desert Valley Medical Center, named a Top 100 Hospitals® ... first U.S. hospital to deploy the wireless Leaf Patient ... prevent hospital acquired pressure ulcers. Desert Valley, ... a community hospital serving some higher risk populations, including ... in the hospital,s emergency department enables the clinical staff ...
Breaking Medicine Technology:Consumers can keep over-the-counter medicine affordable by using store brands 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
(Date:3/27/2015)... March 27, 2015 First Choice Emergency ... The new facility is located 12665 W Lake Houston Pkwy, ... resident of Summerwood, I look forward to delivering the highest ... Sowell, Facility Medical Director of First Choice Emergency Room Summerwood. ... Room made a donation to Summer Creek High School at ...
(Date:3/27/2015)... Kansas City, Mo (PRWEB) March 27, 2015 ... common complications for patients undergoing percutaneous coronary intervention ... Ironically, studies have observed a “risk-treatment paradox,” in ... to gain from treatment are treated less often ... , Researchers at Saint Luke’s Mid America Heart ...
(Date:3/27/2015)... New York, NY (PRWEB) March 27, 2015 ... is seeing more plastic surgery patients travel to the ... Tania Medina. The plastic surgery clinic is turning the ... for international cosmetic surgery patients — with trustworthy services ... important factor when selecting a plastic surgeon. Patients are ...
(Date:3/27/2015)... March 27, 2015 Healthpointe is proud ... Katz, M.D., is now treating knee and hip joint ... Anaheim , Long Beach, and La Mirada. Dr. Stanley ... knee and hip joint disorders as well as chronic ... passionate in returning his patients back to their normal ...
(Date:3/27/2015)... March 27, 2015 On February ... Lounge in the Stardust Penthouse on the rooftop ... Los Angeles’ leading sustainable product TV and film ... unforgettable day-long event, which featured some of the ... sound products and services. , “We were honored ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:Choices Recovery Releases 'Salute to the Oscars' EcoLuxe Lounge Compilation Video 2
... nanoparticles of titanium dioxide in candy, which they eat in ... Published in ACS, journal, Environmental Science & Technology , ... the nanomaterial a source of concern with regard to ... range of consumer goods. In the study, Paul Westerhoff, ...
... Mich. -- As the Diagnostic and Statistical Manual of Mental ... about psychiatric diagnosis is reaching a fever pitch. ... depression, among others, are eliciting great concerns. However, there are ... "Almost no one likes the DSM, but no one knows ...
... , WEDNESDAY, Feb. 15 (HealthDay News) -- Babies ... them, a new study indicates. Researchers from the University ... meaning of the words for certain foods and body parts ... don,t think this type of word comprehension is possible until ...
... Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Florida ... reviewed the progress that has been made at ... Pharmaceutical Company Limited (Takeda). The two-year collaboration focuses ... approaches to obesity. The scientists reported benchmark data ...
... of Exeter, Peninsula College of Medicine and Dentistry (PCMD), ... Service NHS Foundation Trust (SWASFT) and the Royal Devon ... the time it takes from the start of a ... The researchers are from the PCMD-based National Institute ...
... known as photodynamic therapy can destroy cancer tumours, but ... that internal tumours are not treated with the method is ... precise amount of light is administered. However, software developed by ... like being able to solve the problem. "I ...
Cached Medicine News:Health News:Psychiatric diagnoses: Why no one is satisfied 2Health News:Babies May Be Smarter Than You Think 2Health News:Sanford-Burnham and Florida Hospital review obesity research progress with Takeda Pharmaceutical 2Health News:Sanford-Burnham and Florida Hospital review obesity research progress with Takeda Pharmaceutical 3Health News:Operational research seeks benefit for stroke victims 2Health News:Operational research seeks benefit for stroke victims 3Health News:New method makes it easier to treat prostate and pancreatic cancer 2
Provides compression, support, immobilization for the knee in addition to cold / hot therapy...
Provides extended cold therapy to the shoulder area for acute, chronic, or post-surgical applications. The DuraKold products can help reduce pain, edema, and speed recovery....
Provides continuous cold therapy to the knee area for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and facilitate faster rehabilitation....
... designed in 1988 as an attachment to the ... greatly restricts rotation of the cervical spine. , ... be removed while allowing the Collar to remain ... conjunction with the Philadelphia Stabilizer attachment., ,Every ...
Medicine Products: